Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2003

  1. Vaccination Coverage Among Children Enrolled in Head Start Programs, Licensed Child Care Facilities, and Entering School--United States, 2000-01 School Year.  MMWR Morb.Mortal.Wkly.Rep.  3-7-2003, 52 (9): 175- 180.

  2. Notice to Readers: Smallpox Vaccine Adverse Events Among Civilians--United States 2003.  MMWR Morb.Mortal.Wkly.Rep.  3-21-2003, 52(13): 229.

  3. Notice to Readers: Facilitating Influenza and Pneumococcal Vaccination Through Standing Orders Programs.  MMWR Morb.Mortal.Wkly.Rep.  1-31-2003, 52 (4): 68-69.
  4. Smallpox Vaccination and Adverse Reactions: Guidance for Clinicians.  Ann.Pharmacother.  2003, 37 (3): 467-468.

  5. Update: Smallpox Vaccine Adverse Events Among Civilians--United States 2003.  MMWR Morb.Mortal.Wkly.Rep.  4-2-2003, 52 (13): 278-282.

  6. Checklist for Registered Nurses--Smallpox Vaccination.  Kans.Nurse  2003, 78 (2): 17.

  7. Facilities Weigh Risks of Smallpox Vaccination.  OR.Manager.  2003, 19 (2): 7.

  8. Smallpox Vaccine.  Med.Lett.Drugs Ther.  1-6-2003, 45 (1147): 1-4.

  9. ANA Asks Bush to Delay Smallpox Vaccination Plans. Cites Key Concerns About Nurses' Health and Welfare.  Am.Nurse  2003, 35 (1): 1-2.

  10. ACOG Committee Opinion. Immunization During Pregnancy.  Obstet.Gynecol.  2003, 101 (1): 207-212.

  11. Ali, M., Canh, do G., Clemens, J. D., Park, J. K., Seidlein, L., Thiem, V. D., Tho, le H., and Trach, D. D.  The Vaccine Data Link in Nha Trang, Vietnam: A Progress Report on the Implementation of a Database to Detect Adverse Events Related to Vaccinations.  Vaccine  4-2-2003, 21 (15): 1681-1686.

  12. Apuzzio, J., Ganesh, V., Iffy, L., and Al Khan, A.  Varicella Vaccination During Early Pregnancy: A Cause of in Utero Miliary Fetal Tissue Calcifications and Hydrops?  Infect.Dis.Obstet.Gynecol.  2002, 10 (3): 159-160.

  13. Archibald, L. K., Nwanyanwu, O., Kazembe, P. N., Mwansambo, C., Bell, M., Dobbie, H., Reller, L. B., and Jarvis, W. R.  Detection of Bloodstream Pathogens in a Bacille Calmette-Guerin (BCG)-Vaccinated Pediatric Population in Malawi: A Pilot Study.  Clin.Microbiol.Infect.  2003, 9 (3): 234-238.

  14. Attena, F., Serpieri, B., Trinchese, N. M., and Panico, M. G.  Italy s New Vaccination Schedule Reduced Coverage of Poliomyelitis Vaccine in Naples.  Euro.Surveill  2000, 5 (6): 73-74.

  15. Bartlett, J., Borio, L., Radonovich, L., Mair, J. S., O'Toole, T., Mair, M., Halsey, N., Grow, R., and Inglesby, T. V.  Smallpox Vaccination in 2003: Key Information for Clinicians.  Clin.Infect.Dis.  4-1-2003, 36 (7): 883-902.

  16. Baudier, F., Allemand, H., and Lancry, P. J.  [Threats on Vaccination?].  Rev.Epidemiol.Sante Publique  2002, 50 (6): 505-508.

  17. Baumhackl, U., Franta, C., Retzl, J., Salomonowitz, E., and Eder, G.  A Controlled Trial of Tick-Borne Encephalitis Vaccination in Patients With Multiple Sclerosis.  Vaccine  4-1-2003, 21 (S1): S56-S61.

  18. Berg, H. F., Van Gendt, J., Rimmelzwaan, G. F., Peeters, M. F., and Van Keulen, P.  Nosocomial Influenza Infection Among Post-Influenza-Vaccinated Patients With Severe Pulmonary Diseases.  J Infect.  2003, 46 (2): 129-132.

  19. Bhatt, K. M. and Bhatt, S. M.  Anthrax Revisited.  East Afr.Med.J  2002, 79 (7): 364-367.

  20. Borner, N.  Tolerability of Multiple Vaccinations in Travel Medicine.  J Travel.Med.  2003, 10 (2): 112-116.

  21. Bray, M. and Wright, M. E.  Progressive Vaccinia.  Clin.Infect.Dis.  3-15-2003, 36 (6): 766-774.

  22. Brisson, M., Edmunds, W. J., and Gay, N. J.  Varicella Vaccination: Impact of Vaccine Efficacy on the Epidemiology of VZV.  J Med.Virol.  2003, 70 Suppl 1:S31-7. (): S31-S37.

  23. Brodkin, H.  Economic Analysis of Influenza Vaccination and Treatment.  Ann.Intern.Med.  4-1-2003, 138 (7): 607.

  24. Buchwald, U. K. and Pirofski, L.  Immune Therapy for Infectious Diseases at the Dawn of the 21(St) Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers.  Curr.Pharm.Des  2003, 9 (12): 945-968.

  25. Campins, Marti M., Casal, Lombos J., Tarrago, Asensio D., Rodrigo Anoro Mf, M. J., Allepuz, Palau A., and C7llis, Bracons L.  [Persistence of Antibodies Three Years After Vaccination With the 23-Valent Pneumococcal Vaccine].  An Pediatr.(Barc.)  2003, 58 (2): 184-187.

  26. Ciriminna, S. and Cuccia, M.  ["Herd Immunity" After Administration of Pneumococcal Conjugate Vaccine and Its Impact on Vaccination Campaigns].  Ann.Ig  2002, 14 (6 Suppl 7): 39-42.

  27. Cochran, C. E., Smith, D. R., Reid, G., Morrow, H., and Ramirez, J.  Protecting Texas Children: Evidence-Based Recommendations for Improving Childhood Vaccination Rates.  Tex.Med.  2003, 99 (3): 52-60.

  28. Cummings, M. L.  Informed Consent and Investigational New Drug Abuses in the U.S. Military.  Account.Res.  2002, 9 (2): 93-103.

  29. Delgado, Rubio A.  [Vaccination Schedule 2003].  An Pediatr.(Barc.)  2003, 58 (3): 207.

  30. Diabate, V.  [Why Not Include an Anti-Pneumococcal Vaccination in the Anti-Influenza Program?].  Presse Med.  1-18-2003, 32 (2): 51-52.

  31. 33 Dodart, J. C., Bales, K. R., and Paul, S. M.  Immunotherapy for Alzheimer's Disease: Will Vaccination Work?  Trends Mol.Med.  2003, 9 (3): 85-87.

  32. Dropulic, L. K., Rubin, R. H., and Bartlett, J. G.  Smallpox Vaccination and the Patient With an Organ Transplant.  Clin.Infect.Dis.  3-15-2003, 36 (6): 786-788.

  33. du, Toit G. and Weinberg, E. G.  Egg Allergy and MMR Vaccination.  S Afr.Med.J  2003, 93 (2): 113-114.

  34. Earle, C. C.  Influenza Vaccination in Elderly Patients With Advanced Colorectal Cancer.  J Clin.Oncol.  3-15-2003, 21 (6): 1161-1166.

  35. Eko, F. O., Lubitz, W., McMillan, L., Ramey, K., Moore, T. T., Ananaba, G. A., Lyn, D., Black, C. M., and Igietseme, J. U.  Recombinant Vibrio Cholerae Ghosts As a Delivery Vehicle for Vaccinating Against Chlamydia Trachomatis.  Vaccine  4-2-2003, 21 (15): 1694-1703.

  36. Freeman, P. B.  Smallpox Vaccination: A Shot in the Dark?  Optometry.  2003, 74 (3): 141-142.

  37. Gandjour, A.  Economic Analysis of Influenza Vaccination and Treatment.  Ann.Intern.Med.  4-1-2003, 138 (7): 607-608.

  38. Giusti, R. J.  An Outbreak of Varicella Despite Vaccination.  N.Engl.J Med.  4-3-2003, 348 (14): 1405-1407.

  39. Glass, K. and Grenfell, B. T.  Antibody Dynamics in Childhood Diseases: Waning and Boosting of Immunity and the Impact of Vaccination.  J Theor.Biol.  3-7-2003, 221 (1): 121-131.

  40. Gordon, S. M.  Pre-Event Smallpox Vaccination: Unresolved Issues.  Cleve.Clin.J Med.  2003, 70 (2): 80-86.

  41. Greenberg, N., Iversen, A., Hull, L., Unwin, C., Destrange, M., and Wessely, S.  Vaccination Records in Gulf War Veterans.  J Occup.Environ.Med.  2003, 45 (3): 219.

  42. Guala, A., Paoletti, R., Pastore, G., Sinaccio, C., and Pagani, L.  Offering Rubella Vaccination to Sexually Active Adolescents.  Vaccine  4-2-2003, 21 (15): 1561.

  43. Hallander, H. O. and Olin, P.  Marked Decline in Pertussis Followed Reintroduction of Pertussis Vaccination in Sweden.  Euro.Surveill  1999, 4 (12): 128-129.

  44. Jalba, M. S.  Atypical Mycobacterial Infection, Starvation and Effect of BCG Vaccination on Tuberculin Skin Test.  Thorax  2003, 58 (4): 367-368.

  45. James, J. S.  Smallpox Vaccination Followup: IOM Suggests Changes, Widespread Civilian Vaccinations to Begin.  AIDS Treat.News  12-27-2002, 387): 4-5.

  46. Jefferson, T. and Demicheli, V.  Economic Analysis of Influenza Vaccination and Treatment.  Ann.Intern.Med.  4-1-2003, 138 (7): 607.

  47. Karima, T. M., Bukhari, S. Z., Fatani, M. I., Yasin, K. A., Al Afif, K. A., and Hafiz, F. H.  Clinical and Microbiological Spectrum of Meningococcal Disease in Adults During Hajj 2000: An Implication of Quadrivalent Vaccination Policy.  J Pak.Med.Assoc.  2003, 53 (1): 3-7.

  48. Kunz, C.  TBE Vaccination and the Austrian Experience.  Vaccine  4-1-2003, 21 Suppl 1:S50-5. (): S50-S55.

  49. Lane, J. M. and Goldstein, J.  Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options.  Ann.Intern.Med.  3-18-2003, 138 (6): 488-493.

  50. Lee, P. Y. and Peterson, E. D.  Economic Analysis of Influenza Vaccination and Treatment.  Ann.Intern.Med.  4-1-2003, 138 (7): 608-609.

  51. Levy-Bruhl, D., Perrocheau, A., Mora, M., Taha, M., Dromell-Chabrier, S., and Quatresous, I.  Vaccination Campaign Following an Increase in Incidence of Serogroup C Meningococcal Diseases in the Department of Puy-De-Dome (France).  Euro.Surveill  2002, 7 (5): 74-76.

  52. Linton, L. S., Peddecord, K. M., Seidman, R. L., Edwards, C., Ross, S., Gustafson, K., Averhoff, F., and Fishbein, D. B.  Implementing a Seventh Grade Vaccination Law: School Factors Associated With Completion of Required Immunizations.  Prev.Med.  2003, 36 (4): 510-517.

  53. Marks, G. B., Ng, K., Zhou, J., Toelle, B. G., Xuan, W., Belousova, E. G., Mapplsc, and Britton, W. J.  The Effect of Neonatal BCG Vaccination on Atopy and Asthma at Age 7 to 14 Years: An Historical Cohort Study in a Community With a Very Low Prevalence of Tuberculosis Infection and a High Prevalence of Atopic Disease.  J Allergy Clin.Immunol.  2003, 111 (3): 541-549.

  54. Martinez, F., Sanchez, C., Gonzalez, L., Galmes, A., Pachon, I., Pelayo, T., and Pons, C.  Two Outbreaks of Mumps in Children Vaccinated With the Rubini Strain in Spain Indicate Low Vaccine Efficacy.  Euro.Surveill  2000, 5 (7): 80-84.

  55. Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Arico, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., Serruto, D., Litt, D., Kroll, S., Welsch, J. A., Granoff, D. M., Rappuoli, R., and Pizza, M.  Vaccination Against Neisseria Meningitidis Using Three Variants of the Lipoprotein GNA1870.  J Exp.Med.  3-17-2003, 197 (6): 789-799.

  56. Meltzer, M. I. and Bridges, C. B.  Economic Analysis of Influenza Vaccination and Treatment.  Ann.Intern.Med.  4-1-2003, 138 (7): 608.

  57. Montella, M., Crispo, A., Grimaldi, M., Tridente, V., and Fusco, M.  Assessment of Iatrogenic Transmission of HCV in Southern Italy: Was the Cause the Salk Polio Vaccination?  J Med.Virol.  2003, 70 (1): 49-50.

  58. Moran, G. J., Everett, W. W., Karras, D. J., Pesik, N. T., and Sztajnkrycer, M. D.  Smallpox Vaccination for Emergency Physicians: Joint Statement of the AAEM and the SAEM.  J Emerg.Med.  2003, 24 (3): 351-352.

  59. Moreton, J.  MMR Vaccination: Answers to Some Parents' Questions.  J Fam.Health Care  2002, 12 (6): 151-153.

  60. Nakamura, N., Nokura, K., Zettsu, T., Koga, H., Tachi, M., Terada, M., Katoh, H., Itoh, Y., Osawa, H., Ozeki, T., and Yamamoto, H.  Neurologic Complications Associated With Influenza Vaccination: Two Adult Cases.  Intern.Med.  2003, 42 (2): 191-194.

  61. Nassauer, A.  [Legal Security in Respect of Vaccination Procedures].  Gesundheitswesen  2003, 65 Suppl 1:41-2. (): 41-42.

  62. Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., and Iwane, M.  Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke Among the Elderly.  N.Engl.J Med.  4-3-2003, 348 (14): 1322-1332.

  63. Ohkusa, Y.  [An Analysis of the Demand for Influenza Vaccination Among the Elderly in Japan].  Nippon Koshu Eisei Zasshi  2003, 50 (1): 27-38.

  64. Ortiz, De Lejarazu and Eiros, J. M.  [Heading for Systematic Flu Vaccination?].  Med.Clin.(Barc.)  3-15-2003, 120 (9): 340-341.

  65. Osborne, K., Valenciano, M., Veldhuijzen, I., Levy-Bruhl, D., and Pebody, R.  ESEN: A Comparison of Vaccination Programmes - Part Three : Measles Mumps and Rubella.  Euro.Surveill  1998, 3 (12): 115-119.

  66. Osborne, K., Valenciano, M., Veldhuijzen, I., Levy-Bruhl, D., and Pebody, R.  ESEN : A Comparison of Vaccination Programmes Part Two : Pertussis.  Euro.Surveill  1998, 3 (11): 107-110.

  67. Osborne, K., Valenciano, M., Veldhuijzen, I., Levy-Bruhl, D., and Pebody, R.  ESEN : A Comparison of Vaccination Programmes Part One: Diphtheria.  Euro.Surveill  1998, 3 (10): 93-96.

  68. Page, R. C.  Vaccination and Periodontitis: Myth or Reality.  J Int.Acad.Periodontol.  2000, 2 (2): 31-43.

  69. Prinz, C., Hafsi, N., and Voland, P.  Helicobacter Pylori Virulence Factors and the Host Immune Response: Implications for Therapeutic Vaccination.  Trends Microbiol.  2003, 11 (3): 134-138.

  70. Quian, J. W.  An Outbreak of Varicella Despite Vaccination.  N.Engl.J Med.  4-3-2003, 348 (14): 1405-1407.

  71. Rainer, S. R.  Smallpox Vaccination Program Implementation Raises Concerns and Questions.  N.J Nurse  2003, 33 (2): 8.

  72. Roth, Y., Chapnik, J. S., and Cole, P.  Feasibility of Aerosol Vaccination in Humans.  Ann.Otol.Rhinol.Laryngol.  2003, 112 (3): 264-270.

  73. Schoenewald, C., Hughes, C., and Bohnert, L.  Vaccine Information Statements. Are Federal Guidelines Being Followed?  Adv.Nurse Pract.  2003, 11 (2): 63-70.

  74. Schwartz, M. D.  The United States Civilian Smallpox Vaccination Program: Have We Thought Through the Whole Issue?  Pharmacotherapy  2003, 23 (3): 271-273.

  75. Shoji, H. and Kaji, M.  The Influenza Vaccination and Neurological Complications.  Intern.Med.  2003, 42 (2): 139.

  76. Stringer, C.  Post-Exposure Rabies Vaccination.  Nurs.Stand.  2-5-2003, 17 (21): 41-42.

  77. Strongin, R. J. and Salinsky, E.  Who Will Pay for the Adverse Events Resulting From Smallpox Vaccination? Liability and Compensation Issues.  NHPF.Issue.Brief.  3-12-2003, 788): 1-15.

  78. Takahashi, O., Noguchi, Y., Rahman, M., Shimbo, T., Goto, M., Matsui, K., Asai, A., Onishi, M., Koyama, H., Sawada, I., Yoshinaka, T., and Fukui, T.  Influence of Family on Acceptance of Influenza Vaccination Among Japanese Patients.  Fam.Pract.  2003, 20 (2): 162-166.

  79. Tavadia, S., Drummond, A., Evans, C. D., and Wainwright, N. J.  Leucocytoclastic Vasculitis and Influenza Vaccination.  Clin.Exp.Dermatol.  2003, 28 (2): 154-156.

  80. Taylor, J. L., Turner, O. C., Basaraba, R. J., Belisle, J. T., Huygen, K., and Orme, I. M.  Pulmonary Necrosis Resulting From DNA Vaccination Against Tuberculosis.  Infect.Immun.  2003, 71 (4): 2192-2198.

  81. Tugumisirize, F., Tumwine, J. K., and Mworozi, E. A.  Missed Opportunities and Caretaker Constraints to Childhood Vaccination in a Rural Area in Uganda.  East Afr.Med.J  2002, 79 (7): 347-354.

  82. Van Essen, G. A.  Monitoring the Introduction of Universal Influenza Vaccination for the Elderly People in the Netherlands.  Euro.Surveill  1998, 3 (3): 32.

  83. Van Steenbergen, J. E., Spanjaard, L., and Kraayeveld, A. G.  Vaccination Campaign for Meningococcal Disease in a Rural Area in the Netherlands - January 1998.  Euro.Surveill  1999, 4 (2): 18-21.

  84. Wack, R. P.  An Outbreak of Varicella Despite Vaccination.  N.Engl.J Med.  4-3-2003, 348 (14): 1405-1407.

  85. Waecker, N. J., Jr. and Hale, B. R.  Smallpox Vaccination. What the Pediatrician Needs to Know.  Pediatr.Ann.  2003, 32 (3): 178-181.

  86. Wei, K. X., Xie, Y. F., and Yao, Z. F.  [Analysis of HFRS Vaccination Against Hemorrhagic Fever With Renal Syndrome During 1999-2000 in Laiwu City].  Zhonghua Shi Yan.He.Lin.Chuang.Bing.Du Xue.Za Zhi.  2002, 16 (3): 283-285.

  87. Windorfer, A.  [Vaccination. Tasks and Obligations for Surgeons].  Chirurg  2003, 74 (1): 73-80.

  88. Yang, H. M.  The Effects of Re-Infection in Directly Transmitted Infections Modelled With Vaccination.  IMA J Math.Appl.Med.Biol.  2002, 19 (2): 113-135.

Back to Top